382 related articles for article (PubMed ID: 27087491)
21. Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery.
Battaglia L; Gallarate M
Expert Opin Drug Deliv; 2012 May; 9(5):497-508. PubMed ID: 22439808
[TBL] [Abstract][Full Text] [Related]
22. Solid lipid nanoparticles (SLNs) derived from para-acyl-calix[9]-arene: preparation and stability.
Jebors S; Leydier A; Wu Q; Bertino Ghera B; Malbouyre M; Coleman AW
J Microencapsul; 2010; 27(7):561-71. PubMed ID: 20923398
[TBL] [Abstract][Full Text] [Related]
23. Tamoxifen-loaded nanostructured lipid carrier as a drug delivery system: characterization, stability assessment and cytotoxicity.
How CW; Rasedee A; Manickam S; Rosli R
Colloids Surf B Biointerfaces; 2013 Dec; 112():393-9. PubMed ID: 24036474
[TBL] [Abstract][Full Text] [Related]
24. The upcoming field of theranostic nanomedicine: an overview.
Prabhu P; Patravale V
J Biomed Nanotechnol; 2012 Dec; 8(6):859-82. PubMed ID: 23029995
[TBL] [Abstract][Full Text] [Related]
25. Native and Reconstituted Plasma Lipoproteins in Nanomedicine: Physicochemical Determinants of Nanoparticle Structure, Stability, and Metabolism.
Pownall HJ; Rosales C; Gillard BK; Ferrari M
Methodist Debakey Cardiovasc J; 2016 Sep; 12(3):146-150. PubMed ID: 27826368
[TBL] [Abstract][Full Text] [Related]
26. Self-assembled liquid crystalline nanoparticles as an ophthalmic drug delivery system. Part I: influence of process parameters on their preparation studied by experimental design.
Achouri D; Hornebecq V; Piccerelle P; Andrieu V; Sergent M
Drug Dev Ind Pharm; 2015 Jan; 41(1):109-15. PubMed ID: 24188327
[TBL] [Abstract][Full Text] [Related]
27. Lipid nanoparticles as drug/gene delivery systems to the retina.
del Pozo-Rodríguez A; Delgado D; Gascón AR; Solinís MÁ
J Ocul Pharmacol Ther; 2013 Mar; 29(2):173-88. PubMed ID: 23286300
[TBL] [Abstract][Full Text] [Related]
28. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
[TBL] [Abstract][Full Text] [Related]
29. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
[TBL] [Abstract][Full Text] [Related]
30. Design and Characterization of Metformin-Loaded Solid Lipid Nanoparticles for Colon Cancer.
Ngwuluka NC; Kotak DJ; Devarajan PV
AAPS PharmSciTech; 2017 Feb; 18(2):358-368. PubMed ID: 26975870
[TBL] [Abstract][Full Text] [Related]
31. Fabrication and evaluation of lipid nanoparticulates for ocular delivery of a COX-2 inhibitor.
Sharma AK; Sahoo PK; Majumdar DK; Sharma N; Sharma RK; Kumar A
Drug Deliv; 2016 Nov; 23(9):3364-3373. PubMed ID: 27128623
[TBL] [Abstract][Full Text] [Related]
32. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
[TBL] [Abstract][Full Text] [Related]
33. Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release.
Gordillo-Galeano A; Mora-Huertas CE
Eur J Pharm Biopharm; 2018 Dec; 133():285-308. PubMed ID: 30463794
[TBL] [Abstract][Full Text] [Related]
34. Microwave-assisted formulation of solid lipid nanoparticles loaded with non-steroidal anti-inflammatory drugs.
Shah RM; Eldridge DS; Palombo EA; Harding IH
Int J Pharm; 2016 Dec; 515(1-2):543-554. PubMed ID: 27789371
[TBL] [Abstract][Full Text] [Related]
35. Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability.
Gupta S; Kesarla R; Chotai N; Misra A; Omri A
Biomed Res Int; 2017; 2017():5984014. PubMed ID: 28243600
[TBL] [Abstract][Full Text] [Related]
36. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
Dudhipala N; Janga KY
Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
[TBL] [Abstract][Full Text] [Related]
37. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
38. Lipid-enveloped hybrid nanoparticles for drug delivery.
Tan S; Li X; Guo Y; Zhang Z
Nanoscale; 2013 Feb; 5(3):860-72. PubMed ID: 23292080
[TBL] [Abstract][Full Text] [Related]
39. Applications of lipid based formulation technologies in the delivery of biotechnology-based therapeutics.
du Plessis LH; Marais EB; Mohammed F; Kotzé AF
Curr Pharm Biotechnol; 2014; 15(7):659-72. PubMed ID: 25091118
[TBL] [Abstract][Full Text] [Related]
40. Lipid Based Nanosystems for Curcumin: Past, Present and Future.
Nayak AP; Mills T; Norton I
Curr Pharm Des; 2016; 22(27):4247-56. PubMed ID: 27306091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
